Skye Bioscience, Inc Common Stock
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $191 |
Gross Profit | 163 | ||
EBITDA | -7,414 | -5,698 | -4,057 |
EBIT | -7,444 | -5,725 | -4,086 |
Net Income | -7,902 | -5,019 | -4,419 |
Net Change In Cash | 0 | 0 | 191 |
Free Cash Flow | -7,125 | -4,711 | -3,851 |
Cash | 74,120 | 83,342 | 10,336 |
Basic Shares | 38,669 | 27,999 | 12,349 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -124 | -114 | -34 | -1 |
EBITDA | -13,547 | -12,092 | -7,813 | -6,287 |
EBIT | -13,671 | -12,207 | -7,847 | -6,289 |
Net Income | -37,644 | -19,481 | -8,522 | -6,560 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -13,964 | -12,772 | -6,565 | -6,061 |
Cash | 1,256 | 1,244 | 8,983 | 2,469 |
Basic Shares | 7,006 | 493,654 | 1,653 | 1,027 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.10 |
2024-06-30 | -$0.20 |
2024-03-31 | -$0.18 |
2023-12-31 | -$0.63 |
